NIPH Clinical Trials Search

UMIN ID: C000000029

Registered date:28/07/2005

A phase II study of stereotactic body radiation therapy in patients with T1N0M0 non-small cell lung cancer (JCOG0403)

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedT1N0M0 non-small cell lung cancer
Date of first enrollment2004/07/01
Target sample size169
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)stereotactic body radiation therapy


Primary Outcome3-years overall survival
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. No apparent interstitial pneumonitis and fibrosis 2. No active inflamation without oral drugs 3. No double cancer 4. No pregnancy 5. No psychiatric disorder 6. No steroid administration

Related Information


public contact
Name Yasushi Nagata, M.D.
Address 1-2-3 Kasumi, Minami-ku, Hiroshima-shi, Hiroshima, Japan 734-8551 Japan
Affiliation JCOG0403 Coordinating Office Division of Radiation Oncology, Hiroshima University Hospital
scientific contact
Name Masahiro Hiraoka, M.D., P.h.D.
Address 54 Kawahara-cho,Shogoin, Sakyo, Kyoto, 606-8507 Japan Japan
Affiliation Kyoto Universlty Hospital Dept. of Radiation Oncology and Image-applied Therapy